Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Biogen Netherlands B.V.

02 2Biogen Netherlands BV

03 6Biogen Netherlands Bv

04 2Biogen Switzerland Ag

05 1Sandoz GmbH

06 4Sandoz Gmbh

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Arab Health
Not Confirmed
arrow
arrow
Arab Health
Not Confirmed

Natalizumab

Brand Name : Tysabri

Dosage Form : Solution For Injection

Dosage Strength : 150mg

Packaging :

Approval Date : 26/03/2021

Application Number : 20200313000016

Regulatory Info : Approved

Registration Country : Sweden

blank

02

Arab Health
Not Confirmed
arrow
arrow
Arab Health
Not Confirmed

Natalizumab

Brand Name : Tysabri

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 300mg

Packaging :

Approval Date : 27/06/2006

Application Number : 20040916001115

Regulatory Info : Approved

Registration Country : Sweden

blank

03

Arab Health
Not Confirmed
arrow
arrow
Arab Health
Not Confirmed

Natalizumab

Brand Name : Tysabri

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 300mg/15ml

Packaging :

Approval Date : 03/05/2007

Application Number : 57273

Regulatory Info : Allowed

Registration Country : Switzerland

blank

04

Arab Health
Not Confirmed
arrow
arrow
Arab Health
Not Confirmed

Natalizumab

Brand Name : Tysabri

Dosage Form : Solution For Injection

Dosage Strength : 150mg/ml

Packaging :

Approval Date : 04/11/2021

Application Number : 68008

Regulatory Info : Allowed

Registration Country : Switzerland

blank

05

Arab Health
Not Confirmed
arrow
arrow
Arab Health
Not Confirmed

Natalizumab

Brand Name : Tysabri

Dosage Form : Solution For Injection

Dosage Strength : 150mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

06

Arab Health
Not Confirmed
arrow
arrow
Arab Health
Not Confirmed

Natalizumab

Brand Name : Tysabri

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 300mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Not Marketed

Registration Country : Norway

blank

07

Arab Health
Not Confirmed
arrow
arrow
Arab Health
Not Confirmed

Natalizumab

Brand Name : Tysabri

Dosage Form : Solution For Injection

Dosage Strength : 150mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

08

Arab Health
Not Confirmed
arrow
arrow
Arab Health
Not Confirmed

Natalizumab

Brand Name : Tyruko

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 300mg

Packaging :

Approval Date : 21/09/2023

Application Number : 20220627000168

Regulatory Info : Approved

Registration Country : Sweden

blank

09

Arab Health
Not Confirmed
arrow
arrow
Arab Health
Not Confirmed

Natalizumab

Brand Name : Tyruko

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 300mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

10

Arab Health
Not Confirmed
arrow
arrow
Arab Health
Not Confirmed

Natalizumab

Brand Name : Tyruko

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 300mg/15ml

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank